Clinical Trial Update: A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot [NA]

View source ↗

Summary

A double-blind, randomized, controlled trial comparing botulinum toxin type A (Botox) to placebo for idiopathic clubfoot has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Clubfoot

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of British Columbia | Conditions: Idiopathic Clubfoot (Talipes Equinovarus) | NA | Status: COMPLETED